Ministry of Health Labor and Welfare of Japan
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
Japan Lags Behind in COVID-19 Vaccination Goals, Looks to Hasten Approval of Second Vaccine
2021-03-15
Astellas Submits New Drug Application Targeting First ADC Approval for Metastatic Urothelial Cancer in Japan
2021-03-13
COVID-19: Japan’s Fujifilm Holdings Restarts Clinical Trials of Repurposed Drug Avigan, Seeking Approval by October
2021-02-22
Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
2020-07-29Partner
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26